Cigna Group $CI Stock Position Trimmed by Kiltearn Partners LLP

Kiltearn Partners LLP trimmed its position in shares of Cigna Group (NYSE:CI - Free Report) by 5.3% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 89,900 shares of the health services provider's stock after selling 5,000 shares during the quarter. Cigna Group accounts for approximately 6.0% of Kiltearn Partners LLP's investment portfolio, making the stock its 5th largest position. Kiltearn Partners LLP's holdings in Cigna Group were worth $29,719,000 at the end of the most recent reporting period.

• UnitedHealth Group: Pariah to Pole Position to Buy the Dip Levels

Several other hedge funds and other institutional investors have also made changes to their positions in CI. Flaharty Asset Management LLC bought a new position in Cigna Group during the 1st quarter valued at about $28,000. 1248 Management LLC bought a new position in shares of Cigna Group during the first quarter valued at approximately $29,000. Solstein Capital LLC purchased a new stake in shares of Cigna Group in the second quarter worth approximately $29,000. Chilton Capital Management LLC bought a new stake in shares of Cigna Group during the 2nd quarter worth approximately $30,000. Finally, Activest Wealth Management boosted its holdings in Cigna Group by 360.0% during the 1st quarter. Activest Wealth Management now owns 92 shares of the health services provider's stock valued at $30,000 after acquiring an additional 72 shares during the period. Hedge funds and other institutional investors own 86.99% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts have recently commented on CI shares. Jefferies Financial Group reaffirmed a "buy" rating and set a $310.00 target price on shares of Cigna Group in a research report on Monday, November 3rd. Barclays dropped their target price on Cigna Group from $383.00 to $300.00 and set an "overweight" rating on the stock in a research report on Friday, October 31st. UBS Group set a $294.00 price target on Cigna Group in a research report on Wednesday, November 12th. Leerink Partners cut their target price on Cigna Group from $300.00 to $270.00 in a research note on Friday, October 31st. Finally, Weiss Ratings restated a "hold (c)" rating on shares of Cigna Group in a report on Tuesday. One research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $334.05.

• Humana Gains Despite Medicare Advantage Losses—What’s the Catch?

Check Out Our Latest Stock Analysis on CI

Insiders Place Their Bets

In other news, insider Brian C. Evanko sold 5,368 shares of the business's stock in a transaction dated Friday, October 3rd. The stock was sold at an average price of $300.00, for a total value of $1,610,400.00. Following the completion of the transaction, the insider owned 51,182 shares of the company's stock, valued at $15,354,600. The trade was a 9.49% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO David Cordani bought 4,134 shares of the company's stock in a transaction that occurred on Monday, November 3rd. The shares were bought at an average cost of $241.88 per share, for a total transaction of $999,931.92. Following the completion of the acquisition, the chief executive officer owned 157,935 shares of the company's stock, valued at $38,201,317.80. This trade represents a 2.69% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. 0.70% of the stock is owned by corporate insiders.

Cigna Group Stock Performance

• MarketBeat Week in Review – 01/06 - 01/10

CI opened at $278.60 on Thursday. The firm's 50-day moving average price is $285.55 and its 200-day moving average price is $297.73. The company has a market cap of $74.42 billion, a P/E ratio of 15.21, a price-to-earnings-growth ratio of 0.88 and a beta of 0.44. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.65. Cigna Group has a 52-week low of $239.51 and a 52-week high of $350.00.

Cigna Group (NYSE:CI - Get Free Report) last posted its quarterly earnings data on Thursday, October 30th. The health services provider reported $7.83 EPS for the quarter, topping the consensus estimate of $7.64 by $0.19. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The business had revenue of $69.57 billion during the quarter, compared to the consensus estimate of $66.40 billion. During the same period in the previous year, the firm posted $7.51 earnings per share. The business's revenue for the quarter was up 9.5% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, equities analysts anticipate that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 18th. Stockholders of record on Thursday, December 4th will be issued a $1.51 dividend. This represents a $6.04 annualized dividend and a dividend yield of 2.2%. The ex-dividend date of this dividend is Thursday, December 4th. Cigna Group's dividend payout ratio is 26.64%.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Featured Stories

• Five stocks we like better than Cigna Group
• What is the Shanghai Stock Exchange Composite Index?
• Tesla Just Got Called a “Must Own” Stock—Here’s Why
• 3 Tickers Leading a Meme Stock Revival
• Why Gold Loves Trump as Much as Trump Loves Gold
• What is the Dogs of the Dow Strategy? Overview and Examples
• Google's Gemini 3 Sends Broadcom Soaring: TPUs Take Center Stage

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Cigna Group Right Now?

Before you consider Cigna Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.

While Cigna Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here